← Leaderboards
Richard C Koya
University Of California Los Angeles
$2,268,595
Attributed
$3,160,635
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $610.5K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,160,635 · 2
By mechanism
R01$3,160,635 · 2
Top collaborators
- Ruogang Zhao3 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Antoni Ribas$28,929,216
- Robert M Prins$8,963,397
- John Novembre$8,020,131
- Linda M Liau$8,990,878
- James S. Economou$9,911,213
Others in their field
Top investigators on “Adoptive Cell Transfers”
- Carl H. June · University Of Pennsylvania$34,559,203
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Stanley R Riddell · Fred Hutchinson Cancer Center$24,395,993
- David Artis · Weill Medical Coll Of Cornell Univ$21,071,488
- James L Riley · University Of Pennsylvania$20,821,861
- Antoni Ribas · University Of California Los Angeles$20,752,587
Research focus
Adoptive Cell TransfersInsightCell PhysiologyCellsT-LymphocyteMalignant NeoplasmsClinical TrialsTumor AntigensT-Cell ReceptorTumorClinical InvestigationTransforming Growth Factor BetaSignal TransductionCancer TherapyImmunotherapyTransgenic OrganismsImmunologicsCancer ModelAntigen-Presenting CellsCancer ImmunotherapyCancer Immunology ScienceAntigen PresentationAdoptive TransferClinical Efficacy
Grant awards (8)
Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment$603,501
R01 · FY2025 · CA
Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment$570,048
R01 · FY2024 · CA
Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment$610,531
R01 · FY2023 · CA
TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man$352,335
R01 · FY2017 · CA · contact PI
TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man$352,335
R01 · FY2016 · CA · contact PI
TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man$352,335
R01 · FY2015 · CA · contact PI
TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man$293,290
R01 · FY2013 · CA · contact PI
TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man$26,260
R01 · FY2013 · CA · contact PI